You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
A high risk high reward Finnish AI-stock, but not for your grandmothers portfolio
Aiforia is a software company at a commercially early stage whose products enable AI-based image analysis in medicine. The software's primary application is in pathology, where it helps pathologists analyze tissue samples taken from patients. Analyst Antti Luiro comments.
Read the extensive report here https://www.inderes.se/research/aiforia-promisingly-started-growth-journey-just-beginning
Follow Aiforia https://www.inderes.se/companies/Aiforia-Technologies
00:00 Intro
00:27 The big problem Aiforia tries to solve
02:45 How does Aiforia make money?
04:10 Market potential
10:50 Business stickiness
13:35 Dilution risk
16:00 Investment case